Category: Oncology/Hematology
Oncology/Hematology market research reports by DelveInsight
-
Anaplastic Thyroid Cancer - Pipeline Insight, 2024
Anaplastic Thyroid Cancer - Pipeline Insight, 2024 DelveInsight’s, “Anaplastic Thyroid Cancer - Pipeline Insight, 2024,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Anaplastic Thyroid Cancer pipeline landscape. It covers the pipeline drug profiles, including cl ... Read More
-
Anal Cancer - Market Insight, Epidemiology And Market Forecast - 2034
Anal Cancer - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Anal cancer is relatively uncommon, accounting for about 2.7% of all reported gastrointestinal cancers in the United States. Anal cancer is more prevalent among women than men and is most frequently diagnosed betwee ... Read More
-
Cervical Cancer - Market Insight, Epidemiology And Market Forecast - 2034
Cervical Cancer - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The US accounted for the largest market size of cervical cancer, i.e., nearly USD 530 million in 2023. Cervical cancer is most often diagnosed between the ages of 35 and 44. The average age of diagnosis in the U ... Read More
-
Acute Lymphocytic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032
Acute Lymphocytic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights The main treatment options for ALL include chemotherapy, targeted therapy, immunotherapy, surgery, radiation therapy, and stem cell transplant. In 2021, the market size of ALL in the 7MM was app ... Read More
-
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights Urinary tract infections (UTIs) are amongst the most frequent bacterial infections. They can manifest clinically in various ways, from relatively benign, uncomplicated i ... Read More
-
Cutaneous T-Cell Lymphoma - Market Insight, Epidemiology And Market Forecast - 2034
Cutaneous T-Cell Lymphoma - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, in the 7MM the total market size of wAIHA was ~ USD 300 million. wAIHA is the most common type of autoimmune hemolytic anemia, comprising nearly 70–80% of all adult cases and 50% of pediatric ... Read More
-
Advanced Renal Cell Carcinoma- Pipeline Insight, 2024
Advanced Renal Cell Carcinoma- Pipeline Insight, 2024 DelveInsight’s, “Advanced Renal Cell Carcinoma- Pipeline Insight, 2024” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Advanced Renal Cell Carcinoma pipeline landscape. It covers the pipeline drug profiles, i ... Read More
-
Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024
Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024 DelveInsight’s, “Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024” report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in Non-Small-Cell Lung cancer (NSCLC) pipeline landscape. It covers the pipel ... Read More
-
Peripheral T-Cell Lymphoma Market Insight, Epidemiology And Market Forecast - 2034
Peripheral T-Cell Lymphoma Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Dry AMD has the potential to progress to geographic atrophy, a stage characterized by irreversible vision loss caused by the depletion of crucial retinal components such as retinal pigment epithelium (R ... Read More
-
Esophageal Cancer - Market Insight, Epidemiology And Market Forecast - 2034
Esophageal Cancer - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the market size of hemophilia A was the largest in the US among the 7MM, accounting for approximately USD 5,000 million, which is further expected to increase by 2034. In September 2023, concizumab wa ... Read More
-
HER2 Negative Breast Cancer- Pipeline Insight, 2024
HER2 Negative Breast Cancer- Pipeline Insight, 2024 DelveInsight’s, “HER2 Negative Breast Cancer- Pipeline Insight, 2024” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in HER2 Negative Breast Cancer pipeline landscape. It covers the pipeline drug profiles, includi ... Read More
-
CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Market Insight, Epidemiology And Market Forecast - 2032
CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights In 2023, the market size of epidermolysis bullosa was highest in the US among the 7MM, accounting for approximately USD 1,300 million, which is further expected to increase by ... Read More
-
Ocular Melanoma - Market Insight, Epidemiology And Market Forecast - 2034
Ocular Melanoma - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Stargardt disease, also known as Stargardt’s macular dystrophy or juvenile macular degeneration, is a rare genetic eye disease that happens when fatty material builds up on the macula — the small part of the ret ... Read More
-
Triple Negative Breast Cancer (TNBC) - Market Insight, Epidemiology And Market Forecast - 2032
Triple Negative Breast Cancer (TNBC) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights Breast cancer is a genetically and clinically heterogeneous disease with multiple subtypes. The classification of these subtypes has evolved over the years. The most common and widely accept ... Read More
-
Metastatic Non-Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast -2032
Metastatic Non-Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast -2032 Key Highlights NSCLC market size has seen a revolutionary change in the last decade owing to the increase in incident case of NSCLC, continuous uptake of approved therapies mainly immune checkpoint inhibit ... Read More
-
HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032
HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights Recent advancements in HER2 treatments have enhanced HER2-positive breast cancer management, yet relapse remains a primary challenge due to disease heterogeneity and drug resistance mechanisms. In 20 ... Read More
-
Metastatic Prostate Cancer - Market Insight, Epidemiology And Market Forecast - 2032
Metastatic Prostate Cancer - Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight's ""Metastatic Prostate Cancer - Market Insights, Epidemiology, and Market Forecast-2032"" report delivers an in-depth understanding of the metastatic prostate cancer, historical and forecasted epidemio ... Read More
-
Metastatic HR+/HER2− Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032
Metastatic HR+/HER2− Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032 Key Highlights Breast cancer is a genetically and clinically heterogeneous disease with multiple subtypes. The HR+/HER2- subtype is the most common of all the breast cancer subtypes. The total market size in ... Read More
-
Non-metastatic Prostate Cancer (nmPC) - Market Insight, Epidemiology and Market Forecast -2032
Non-metastatic Prostate Cancer (nmPC) - Market Insight, Epidemiology and Market Forecast -2032 Key Highlights Non-metastatic prostate cancer (nmPC) refers to prostate cancer that has not spread beyond the prostate gland and nearby lymph nodes. It is a localized form of prostate cancer. When prostate ... Read More
-
Triple Negative Breast Cancer Epidemiology Forecast - 2032
Triple Negative Breast Cancer Epidemiology Forecast - 2032 Key Highlights Breast cancer is a genetically and clinically heterogeneous disease with multiple subtypes. The classification of these subtypes has evolved over the years. The most common and widely accepted classification of breast cancer i ... Read More
-
Cutaneous T-Cell Lymphoma (CTCL)- Pipeline Insight, 2023
Cutaneous T-Cell Lymphoma (CTCL)- Pipeline Insight, 2023 DelveInsight’s, “Cutaneous T-Cell Lymphoma (CTCL)- Pipeline Insight, 2023” report provides comprehensive insights about 30+ companies and 35+ pipeline drugs in Cutaneous T-Cell Lymphoma pipeline landscape. It covers the pipeline drug profiles, ... Read More
-
Chronic Myelomonocytic Leukaemia- Pipeline Insight, 2023
Chronic Myelomonocytic Leukaemia- Pipeline Insight, 2023 DelveInsight’s, “Chronic Myelomonocytic Leukaemia- Pipeline Insight, 2023” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Chronic Myelomonocytic Leukaemia pipeline landscape. It covers the pipeline drug pr ... Read More
-
T cell Lymphoma -Pipeline Insight, 2023
T cell Lymphoma -Pipeline Insight, 2023 DelveInsight’s, “T-cell Lymphoma -Pipeline Insight, 2023” report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in T-cell Lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage p ... Read More
-
Non Muscle Invasive Bladder Cancer- Pipeline Insight, 2023
Non Muscle Invasive Bladder Cancer- Pipeline Insight, 2023 DelveInsight’s, “Non Muscle Invasive Bladder Cancer- Pipeline Insight, 2023” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the pipeline d ... Read More
-
Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS)-inhibitors – Market Insights, Epidemiology and Market Forecast – 2032
Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS)-inhibitors – Market Insights, Epidemiology and Market Forecast – 2032 Key Highlights: In Japan, the contribution of KRAS mutations is lower compared to Western countries like the United States and Europe In the United States, KRASG12C is present in ~ ... Read More
Research Assistance
